Global respiratory inhalers market is estimated to be valued at USD 33.11 Bn in 2024 and is expected to reach USD 49.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to ...
Pulmicort (budesonide) is an asthma drug that’s considered safe to use while pregnant. The drug passes into breast milk but is also considered safe to use while breastfeeding. Pulmicort is ...
Drug firm AstraZeneca Pharma India Ltd on Monday (November 18) said it has received import and market permission from the Drugs Controller General of India (DCGI) for its inhalation preparation, ...
People who might benefit from being placed on an inhaled steroid like fluticasone or Pulmicort or a combination agent like Advair include those who ... Prescribers' Digital Reference. Albuterol ...